Early results show a decline in PSA, an indicator of prostate cancer in the bloodstream; evidence of tumor shrinkage; and an increased immune system response, according to Glenn Liu, principal investigator at the UW-Madison Carbone Cancer Center where ...
A mathematical crystal ball gazes into future of prostate cancer ...
The chemotherapy docetaxel is widely accepted as a standard therapy for metastatic castration-resistant prostate cancer. But 10-20 percent of patients will have ...and more »
No comments:
Post a Comment